Role of depression and inflammation in incident coronary heart disease events

American Journal of Cardiology

Volumn 96, Issue 7, 2005, Pages 1016-1021

  Shimbo, Daichi ^a   Chaplin, William ^b   Crossman, Daniel ^a   Haas, Donald ^c   Davidson, Karina W ^a,c  

^a NewYork Presbyterian Hospital   (United States)

^b ST JOHN'S UNIVERSITY   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

AGING; ANHEDONIA; ANOREXIA; ANXIETY; BODY MASS; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; DEPRESSION; DIABETES MELLITUS; DISEASE MARKER; FAMILY HISTORY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; INFLAMMATION; ISCHEMIC HEART DISEASE; MENTAL DISEASE; MENTAL STRESS; MOOD; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PSYCHOLOGIC TEST; REVIEW; REWARD; SEX DIFFERENCE; SLEEP DISORDER; SOMNOLENCE; SYMPTOM;

ANIMALS; BIOLOGICAL MARKERS; CORONARY DISEASE; DEPRESSIVE DISORDER; HUMANS; INFLAMMATION MEDIATORS; RISK FACTORS;

EID: 25444460159     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.05.064     Document Type: Review

References (34)

1. M. Naghavi, P. Libby, E. Falk, S.W. Casscells, S. Litovsky, J. Rumberger, J.J. Badimon, C. Stefanadis, P. Moreno, G. Pasterkamp From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II Circulation 108 2003 1772 1778
2. A. Rozanski, J.A. Blumenthal, K.W. Davidson, P.G. Saab, L. Kubzansky The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice the emerging field of behavioral cardiology J Am Coll Cardiol 45 2005 637 651
3. A.K. Ferketich, J.A. Schwartzbaum, D.J. Frid, M.L. Moeschberger Depression as an antecedent to heart disease among women and men in the NHANES I study. National Health and Nutrition Examination Survey Arch Intern Med 160 2000 1261 1268
4. S. Wassertheil-Smoller, S. Shumaker, J. Ockene, G.A. Talavera, P. Greenland, B. Cochrane, J. Robbins, A. Aragaki, J. Dunbar-Jacob Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI) Arch Intern Med 164 2004 289 298
5. R. Rugulies Depression as a predictor for coronary heart disease. a review and meta-analysis Am J Prev Med 23 2002 51 61
6. R. Corti, V. Fuster, J.J. Badimon Pathogenetic concepts of acute coronary syndromes J Am Coll Cardiol 41 2003 7S 14S
7. P.M. Ridker, C.H. Hennekens, J.E. Buring, N. Rifai C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843
8. P.M. Ridker, N. Rifai, M.J. Stampfer, C.H. Hennekens Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men Circulation 101 2000 1767 1772
9. P.M. Ridker Clinical application of C-reactive protein for cardiovascular disease detection and prevention Circulation 107 2003 363 369
10. T.A. Pearson, G.A. Mensah, R.W. Alexander, J.L. Anderson, R.O. Cannon III, M. Criqui, Y.Y. Fadl, S.P. Fortmann, Y. Hong, G.L. Myers Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 2003 499 511
11. P.M. Ridker, J.E. Buring, N. Rifai Soluble P-selectin and the risk of future cardiovascular events Circulation 103 2001 491 495
12. P.M. Ridker, C.H. Hennekens, B. Roitman-Johnson, M.J. Stampfer, J. Allen Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men Lancet 351 1998 88 92
13. W.J. Kop, J.S. Gottdiener, C.M. Tangen, L.P. Fried, M.A. McBurnie, J. Walston, A. Newman, C. Hirsch, R.P. Tracy Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia Am J Cardiol 89 2002 419 424
14. D.B. Panagiotakos, C. Pitsavos, C. Chrysohoou, E. Tsetsekou, C. Papageorgiou, G. Christodoulou, C. Stefanadis Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study Eur Heart J 25 2004 492 499
15. D.E. Ford, T.P. Erlinger Depression and C-reactive protein in US adults data from the Third National Health and Nutrition Examination Survey Arch Intern Med 164 2004 1010 1014
16. G.E. Miller, K.E. Freedland, R.M. Carney, C.A. Stetler, W.A. Banks Pathways linking depression, adiposity, and inflammatory markers in healthy young adults Brain Behav Immun 17 2003 276 285
17. R. Dantzer, A. Aubert, R.M. Bluthe, G. Gheusi, S. Cremona, S. Laye, J.P. Konsman, P. Parnet, K.W. Kelley Mechanisms of the behavioural effects of cytokines Adv Exp Med Biol 461 1999 83 105
18. L. Capuron, A. Ravaud, R. Dantzer Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy J Clin Oncol 18 2000 2143 2151
19. A. Reichenberg, R. Yirmiya, A. Schuld, T. Kraus, M. Haack, A. Morag, T. Pollmacher Cytokine-associated emotional and cognitive disturbances in humans Arch Gen Psychiatry 58 2001 445 452
20. U. Schonbeck, P. Libby Inflammation, immunity, and HMG-CoA reductase inhibitors statins as antiinflammatory agents? Circulation 109 2004 II18 II26
21. Y. Young-Xu, K.A. Chan, J.K. Liao, S. Ravid, C.M. Blatt Long-term statin use and psychological well-being J Am Coll Cardiol 42 2003 690 697
22. C.C. Yang, S.S. Jick, H. Jick Lipid-lowering drugs and the risk of depression and suicidal behavior Arch Intern Med 163 2003 1926 1932
23. M.F. Muldoon, S.D. Barger, C.M. Ryan, J.D. Flory, J.P. Lehoczky, K.A. Matthews, S.B. Manuck Effects of lovastatin on cognitive function and psychological well-being Am J Med 108 2000 538 546
24. R.A. Stewart, K.J. Sharples, F.M. North, D.B. Menkes, J. Baker, J. Simes Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. The LIPID Study Investigators Arch Intern Med 160 2000 3144 3152
25. N. Lozovaya, A.D. Miller Chem neuroimmunology health in a nutshell bidirectional communication between immune and stress (limbic-hypothalamic- pituitary-adrenal) systems Chembiochem 4 2003 466 484
26. A. Steptoe, G. Willemsen, N. Owen, L. Flower, V. Mohamed-Ali Acute mental stress elicits delayed increases in circulating inflammatory cytokine levels Clin Sci (London) 101 2001 185 192
27. U.H. Frommberger, J. Bauer, P. Haselbauer, A. Fraulin, D. Riemann, M. Berger Interleukin-6-(IL-6) plasma levels in depression and schizophrenia comparison between the acute state and after remission Eur Arch Psychiatry Clin Neurosci 247 1997 228 233
28. H. Anisman, A.V. Ravindran, J. Griffiths, Z. Merali Interleukin-1 beta production in dysthymia before and after pharmacotherapy Biol Psychiatry 46 1999 1649 1655
29. J. Griffiths, A.V. Ravindran, Z. Merali, H. Anisman Dysthymia a review of pharmacological and behavioral factors Mol Psychiatry 5 2000 242 261
30. M. Maes, C. Song, A.H. Lin, S. Bonaccorso, G. Kenis, R. De Jongh, E. Bosmans, S. Scharpe Negative immunoregulatory effects of antidepressants inhibition of interferon-gamma and stimulation of interleukin-10 secretion Neuropsychopharmacology 20 1999 370 379
31. J.P. Empana, D.H. Sykes, G. Luc, I. Juhan-Vague, D. Arveiler, J. Ferrieres, P. Amouyel, A. Bingham, M. Montaye, J.B. Ruidavets Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men the Prospective Epidemiological Study of Myocardial Infarction (PRIME) Circulation 111 2005 2299 2305
32. H.C. Kraemer, E. Stice, A. Kazdin, D. Offord, D. Kupfer How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors Am J Psychiatry 158 2001 848 856
33. M.E. Sobel Asymptotic intervals for indirect effects in structural equation models Sociol Methodol 13 1982 290 312
34. D. Shimbo, K.W. Davidson, D.C. Haas, V. Fuster, J.J. Badimon Negative impact of depression on outcomes in patients with coronary artery disease mechanisms, treatment considerations, and future directions J Thromb Haemost 3 2005 897 908